These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1433799)

  • 61. Leukocytoclastic vasculitis after high-dose methotrexate.
    Navarro M; Pedragosa R; Lafuerza A; Rubio D; Huguet P
    Ann Intern Med; 1986 Sep; 105(3):471-2. PubMed ID: 3461742
    [No Abstract]   [Full Text] [Related]  

  • 62. Methotrexate.
    O'Marcaigh AS; Betcher DL
    J Pediatr Oncol Nurs; 1993 Oct; 10(4):158-60. PubMed ID: 8251124
    [No Abstract]   [Full Text] [Related]  

  • 63. The effect of water deprivation on the pharmacokinetics of methotrexate in rats.
    Hwang SJ; Park JM; Lee WI; Kim ON; Lee MG
    Biopharm Drug Dispos; 1995 Apr; 16(3):245-50. PubMed ID: 7787136
    [No Abstract]   [Full Text] [Related]  

  • 64. Potential problems with methotrexate prescribing.
    Davies J
    Br J Rheumatol; 1994 Oct; 33(10):991. PubMed ID: 7921767
    [No Abstract]   [Full Text] [Related]  

  • 65. Is methotrexate carcinogenic?
    Turnbull C; Roach M
    Br Med J; 1980 Sep; 281(6243):808. PubMed ID: 7427456
    [No Abstract]   [Full Text] [Related]  

  • 66. Mega doses of methotrexate in the treatment of osteosarcoma.
    Iqbal MP; Malik IA
    J Pak Med Assoc; 1990 Oct; 40(10):248-51. PubMed ID: 2123265
    [No Abstract]   [Full Text] [Related]  

  • 67. [The use of medium- and high-dose methotrexate in the management of malignant childhood diseases].
    Nagy K; Hunyadi K; Velkey L
    Orv Hetil; 1983 Jun; 124(24):1433-9. PubMed ID: 6576318
    [No Abstract]   [Full Text] [Related]  

  • 68. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical significance of non-renal elimination mechanisms of methotrexate (MTX)].
    Erttmann R; Gkanatsas A
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):516-9. PubMed ID: 3876505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
    Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
    Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy.
    Iqbal MP; Malik I; Mehboobali N
    J Pak Med Assoc; 1992 Aug; 42(8):193-6. PubMed ID: 1433799
    [No Abstract]   [Full Text] [Related]  

  • 72. [Characteristics of low-dose methotrexate therapy in rheumatoid diseases].
    Weber MH
    Internist (Berl); 1993 Sep; 34(9):866-70. PubMed ID: 8407205
    [No Abstract]   [Full Text] [Related]  

  • 73. Osteosarcoma--is there a role for oral low-dose methotrexate.
    Harris MB
    Cancer Invest; 1989; 7(4):357-60. PubMed ID: 2686815
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.